Physician profile
Thomas Edwards
NPI 1821451345
$4,360.60
in general payments reported to CMS, 2019-2025
8 companies · $28.24 in 2025
The $28.24 reported for 2025 was less than what a typical Otolaryngic Allergy provider received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $57.36 · 2022: $20.08 · 2023: $108 · 2024: $4,147 · 2025: $28.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,912 · Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,912.00 |
| Food and Beverage | $371.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $4,019.57 | 2023-2024 | |
| Integra Lifesciences Corporation | $156.05 | 2024 | Acclarent Aera |
| Glaxosmithkline, LLC. | $79.30 | 2024 | |
| Depuy Synthes Sales INC. | $37.78 | 2020 | |
| Stryker Corporation | $28.24 | 2025 | Audion Et Dilation System, Xpress Loprofile, Fiagon Navigation Unit |
| Bausch & Lomb Americas INC. | $20.08 | 2022 | |
| Baxter Healthcare | $19.58 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.